Prevalence and Factors Associated with Long COVID Symptoms among U.S. Adults, 2022.

Nguyen, Kimberly H; Bao, Yingjun; Mortazavi, Julie; Allen, Jennifer D; Chocano-Bedoya, Patricia O; Corlin, Laura (2024). Prevalence and Factors Associated with Long COVID Symptoms among U.S. Adults, 2022. Vaccines, 12(1), p. 99. MDPI 10.3390/vaccines12010099

[img]
Preview
Text
vaccines-12-00099-v2.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (239kB) | Preview

Long COVID and its symptoms have not been examined in different subpopulations of U.S. adults. Using the 2022 BRFSS (n = 445,132), we assessed long COVID and each symptom by sociodemographic characteristics and health-related variables. Multivariable logistic regression was conducted to examine factors associated with long COVID and the individual symptoms. Prevalence differences were conducted to examine differences in long COVID by vaccination status. Overall, more than one in five adults who ever had COVID-19 reported symptoms consistent with long COVID (21.8%). The most common symptom was tiredness or fatigue (26.2%), followed by difficulty breathing or shortness of breath (18.9%), and loss of taste or smell (17.0%). Long COVID was more common among adults under 65 years, women, American Indian or Alaska Native or other/multi race group, smokers, and people with a disability, depression, overweight or obesity compared to their respective counterparts. The prevalence of long COVID was higher among unvaccinated adults (25.6%) than vaccinated adults (21.6%) overall, and for 20 of 32 subgroups assessed. These findings underscore the benefits of vaccination, the importance of early treatment, and the need to better inform health care resource allocation and support services for those experiencing long COVID.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Medical Education > Institute of General Practice and Primary Care (BIHAM)

UniBE Contributor:

Chocano Bedoya, Patricia Orializ

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

2076-393X

Publisher:

MDPI

Language:

English

Submitter:

Pubmed Import

Date Deposited:

22 Jan 2024 16:40

Last Modified:

23 Jan 2024 18:26

Publisher DOI:

10.3390/vaccines12010099

PubMed ID:

38250912

Uncontrolled Keywords:

COVID-19 outcomes COVID-19 vaccination adults disparities long COVID symptoms vaccine confidence vaccine hesitancy

BORIS DOI:

10.48350/191979

URI:

https://boris.unibe.ch/id/eprint/191979

Actions (login required)

Edit item Edit item
Provide Feedback